SVRA Quick Ratio | Savara Inc

Savara Inc Quick Ratio

The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

Savara Inc quick ratio for the quarter ending 2026-06-30 was 9.83, a 8.50% decline year-over-year.
Savara Inc quick ratio for the quarter ending 2026-03-31 was 13.05, a 9.99% decline year-over-year.
Savara Inc quick ratio for the quarter ending 2025-12-31 was 11.56, a 13.33% decline year-over-year.
Savara Inc quick ratio for the quarter ending 2025-09-30 was 7.42, a 56.74% decline year-over-year.
Savara Inc quick ratio for fiscal 2025 was 11.56, a 13.33% decline from fiscal 2024.
Savara Inc quick ratio for fiscal 2024 was 13.33, a 12.95% decline from fiscal 2023.
Savara Inc quick ratio for fiscal 2023 was 15.32, a 28.61% decline from fiscal 2022.
Savara Inc quick ratio for fiscal 2022 was 21.45, a 95.15% increase from fiscal 2021.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2026-06-30	9.83	$173.03M	$17.6M
2026-03-31	13.05	$202.77M	$15.54M
2025-12-31	11.56	$235.7M	$20.4M
2025-09-30	7.42	$124.39M	$16.76M
2025-06-30	10.75	$146.44M	$13.63M
2025-03-31	14.5	$172.5M	$11.9M
2024-12-31	13.33	$196.33M	$14.72M
2024-09-30	17.16	$219.44M	$12.79M
2024-06-30	10.77	$121.52M	$11.29M
2024-03-31	14.58	$143.04M	$9.81M
2023-12-31	15.32	$162.32M	$10.6M
2023-09-30	18.77	$168.25M	$8.96M
2023-06-30	17.87	$105.18M	$5.89M
2023-03-31	23.32	$114.78M	$4.92M
2022-12-31	21.45	$125.88M	$5.87M
2022-09-30	25.97	$134.08M	$5.16M
2022-06-30	38.43	$142.44M	$3.71M
2022-03-31	9.3	$151.8M	$16.32M
2021-12-31	10.99	$161.17M	$14.66M
2021-09-30	16.02	$170.81M	$10.66M
2021-06-30	32.06	$180.67M	$5.64M
2021-03-31	26.74	$192.71M	$7.21M
2020-12-31	10.05	$82.19M	$8.17M
2020-09-30	12.35	$94.34M	$7.64M
2020-06-30	15.44	$99.61M	$6.45M
2020-03-31	13.58	$104.99M	$7.73M
2019-12-31	11.19	$121.76M	$10.88M
2019-09-30	12.82	$106.28M	$8.29M
2019-06-30	12.34	$111.73M	$9.05M
2019-03-31	11.79	$105.18M	$8.92M
2018-12-31	15.28	$110.83M	$7.25M
2018-09-30	9.99	$112.05M	$11.22M
2018-06-30	9.94	$74.76M	$7.52M
2018-03-31	15.78	$84.98M	$5.39M
2017-12-31	15.68	$94.31M	$6.02M
2017-09-30	8.77	$53.29M	$6.08M
2017-06-30	7.51	$61.13M	$8.14M
2017-03-31	1.59	$10.46M	$6.59M
2016-12-31	3.87	$13.37M	$3.46M
2016-09-30	0.74	$15.51M	$20.89M
2016-06-30	0.55	$14.06M	$25.36M
2016-03-31	1.04	$23.52M	$22.67M
2015-12-31	0.72	$16.68M	$23.17M
2015-09-30	2.38	$32.21M	$13.52M
2015-06-30	1.96	$21.21M	$10.8M
2015-03-31	3.04	$27.93M	$9.18M
2014-12-31	1.5	$12.69M	$8.44M
2014-09-30	3.46	$25.98M	$7.51M
2014-06-30	4.59	$26.37M	$5.75M
2014-03-31	4.84	$29.85M	$6.17M
2013-12-31	5.31	$25.68M	$4.83M
2013-09-30	7.6	$30.23M	$3.98M
2013-06-30	16.05	$53.42M	$3.33M
2013-03-31	10.11	$32.01M	$3.16M
2012-12-31	14.2	$36.51M	$2.57M
2012-09-30	15	$39.9M	$2.66M
2012-06-30	17.28	$43.07M	$2.49M
2012-03-31	23.67	$46.05M	$1.95M
2011-12-31	20.54	$50.7M	$2.47M
2011-09-30	12.27	$38.29M	$3.12M
2011-06-30	17.75	$41.96M	$2.36M
2010-12-31	15.53	$27.98M	$1.8M

Annual Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2025-12-31	11.56	$235.7M	$20.4M
2024-12-31	13.33	$196.33M	$14.72M
2023-12-31	15.32	$162.32M	$10.6M
2022-12-31	21.45	$125.88M	$5.87M
2021-12-31	10.99	$161.17M	$14.66M
2020-12-31	10.05	$82.19M	$8.17M
2019-12-31	11.19	$121.76M	$10.88M
2018-12-31	15.28	$110.83M	$7.25M
2017-12-31	15.68	$94.31M	$6.02M
2016-12-31	3.87	$13.37M	$3.46M
2015-12-31	0.72	$16.68M	$23.17M
2014-12-31	1.5	$12.69M	$8.44M
2013-12-31	5.31	$25.68M	$4.83M
2012-12-31	14.2	$36.51M	$2.57M
2011-12-31	20.54	$50.7M	$2.47M
2010-12-31	15.53	$27.98M	$1.8M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
MANNKIND CORP (MNKD)	United States	$1.058B	-30.41
Alto Neuroscience, Inc. (ANRO)	United States	$1.065B	-11.02
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
Corvus Pharmaceuticals, Inc. (CRVS)	United States	$0.994B	-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)	United States	$1.116B	10.93
Kura Oncology, Inc. (KURA)	United States	$0.967B	-3.29
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19
Seaport Therapeutics, Inc. (SPTX)	United States	$1.131B